Shalini Vinod
@shalinivinod13
Followers
870
Following
2K
Media
429
Statuses
2K
Radiation Oncologist l Conjoint Professor UNSW l Fitness Freak l Own views l #LCSM #BCSM #quality #radonc
Joined August 2020
Time for a RCT comparing hypofractionation 55/20 vs conventional fractionation 60/30 for Stage III NSCLC? @yysoon01 @Eric73363938 @HegiFiona @TROGfightcancer Any 🇦🇺 med oncs interested in joining our team?.
onlinelibrary.wiley.com
Four weeks of moderately hypofractionated chemoradiation in the definitive treatment of unresectable Stage 3 non–small cell lung cancer is an appealing strategy to reduce the treatment burden. This...
1
4
7
RT @TheLancetOncol: Online First:. New Research: Global #LINAC requirements and personalised country recommendations: a cross-sectional, po….
0
5
0
👏🏽👏🏽👏🏽Amazing to see incorporation of frailty screening (G8) in assessment & reporting. Should be standard for all #clinicaltrials recruiting older people. @SIOGorg.
Single-modality endocrine therapy versus #radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early #BreastCancer (EUROPA).@TheLancetOncol . ▶️ Share Link – 50 days' free access to the article (Jan 31, 2025):.
0
2
7
RT @piet_ost: I think everyone should read this review of radiotherapy vs systemic trials and endpoints selected. Why is the world focused….
0
29
0
RT @gwalls89: Thoracic RadOncs should check out our paper in this month's Clinical Oncology. . We worked with the I….
0
6
0
RT @NiuSanford: Our comprehensive assessment of NCI cooperative group trials is out in @JNCI_Now! . If you are involved or enrolling in coo….
0
60
0
RT @HegiFiona: Lung cancer breakthroughs made 2024 one of the most consequential years for lung cancer researchers and clinicians. Join h….
0
6
0
RT @Mat_Guc: Radiation Oncology is characterized by rapid innovation. Dissemination & implementation are important aspects to bring this pr….
0
14
0
🙏🏽 @IASLC for showcasing our nurse led geriatric oncology model of care for older patients with #lungcancer. Study Demonstrates Multidisciplinary Approach Can Improve Care for Elderly Lung Cancer Patients @NicoleHKnox @meera_agar @DrLouiseHickman.
ilcn.org
During the 2024 WCLC, Dr. Shalini Vinod reviewed data showing that a nurse-led care model for geriatric patients outperformed a medical-led model.
1
1
4
👏🏽👏🏽👏🏽 @NicoleHKnox on 1st PhD pub. Examining unmet needs in older adults with lung cancer @NicoleHKnox @meera_agar @DrLouiseHickman
0
2
8
RT @IASLC: Angeline Low is not just a survivor—she’s a powerful voice for lung cancer awareness and advocacy! In her heartfelt message, she….
0
2
0
RT @TOGAANZ: Lung cancer is the leading cause of cancer death in women. Don't ignore the signs!. Thanks for coming on the journey with us t….
0
4
0
RT @_ShankarSiva: @targetingcancer nails it again - a compelling story about the ease of curing #lungcancer with SABR!.👀- .
0
4
0
Thought provoking Danish study. MDTs cornerstone of oncology Rx esp #lungcancer. Dist’n of 60 fictitious cases shows poor agreement on stage & Rx intent esp St III NSCLC. Urgent need for #quality indicators to measure process & outcomes @AusLucap
bmccancer.biomedcentral.com
Introduction This study aimed to evaluate the consistency of lung cancer case assessments across multidisciplinary team (MDT) sites in Denmark. The goal was to appraise the comparability of outcomes...
0
0
2
RWD from 🇨🇳on the % of unresectable patients with St III NSCLC whose cancers become resectable post chemoIO. 30% of cancers remain unresectable! Caution advised on using neoadjuvant approach for these cases. @DrewMoghanaki @BrendonStilesMD
0
0
2
Medical mistrust is a barrier to #lungcancer screening regardless of race in 🇺🇸Food for thought with upcoming #lungcancer screening in 🇦🇺@CancerAustralia @nicole_rankin8n
tandfonline.com
Although medical mistrust is associated with lower cancer screening uptake among racial minorities, such as African Americans, potential impacts on cancer screening among White Americans are genera...
0
0
5
Really important for referring clinicians to be aware of #SABR as non-invasive safe & effective Rx for early stage lung cancer. Patients with comorbidities or poor pulmonary fxn should not be precluded from screening @RACGP @CancerAustralia @cancerNSW @nicole_rankin8n.
Thank you to our wonderful patient Derek for sharing his story, and for all those who helped with the creation of this video. With the introduction of #lungcancerscreening set for July 1st 2025 in Australia there will be more and more patients like Derek diagnosed with early.
0
2
6
RT @CancerAustralia: It's #LungCancerAwarenessMonth. For information on #lungcancer including risk factors, symptoms & treatment visit: htt….
0
2
0